(Phys.org)—As the cold and flu season makes its annual visit, a team of researchers, using Argonne's Advanced Photon Source, continue to complete a detailed map of the human adenovirus—one of several viruses responsible ...
Analytical Chemistry
Oct 22, 2012
0
0
(Phys.org)—Smart viruses find ways around host defenses. In the case of the influenza viruses A and B, rapid genetic changes and resistance to available therapies make it hard to combat flu epidemics in humans. Mortality ...
Biochemistry
Oct 11, 2012
0
0
(Phys.org)—Understanding why proteins interact with certain specific molecules and not with the myriad others in their environment is a major goal of molecular biology. Now, in a series of recent papers, researchers describe ...
Biochemistry
Oct 2, 2012
0
0
Computer-designed proteins are under construction to fight the flu. Researchers are demonstrating that proteins found in nature, but that do not normally bind the flu, can be engineered to act as broad-spectrum antiviral ...
Biotechnology
Jun 1, 2012
0
0
An international research team has manufactured a new protein that can combat deadly flu epidemics.
Biotechnology
May 27, 2012
0
0
Researchers at the University of Leeds are developing a way to 'barcode' viral diseases to rapidly test new outbreaks for potentially lethal mutations.
Cell & Microbiology
May 13, 2012
0
0
(AP) -- The U.S. government's biosecurity advisers said Friday they support publishing research studies showing how scientists made new easy-to-spread forms of bird flu because the studies, now revised, don't reveal details ...
Other
Mar 30, 2012
6
0
Bird flu experts meeting in Geneva on Friday ruled that controversial research on a mutant form of the virus potentially capable of being spread among humans should be made public.
Other
Feb 17, 2012
0
0
(PhysOrg.com) -- In the current issue of Science, researchers at Michigan State University demonstrate how a new virus evolves, which sheds light on how easy it can be for diseases to gain dangerous mutations.
Cell & Microbiology
Jan 26, 2012
0
0
Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, Ph.D., a researcher at Duke-NUS Graduate Medical ...
Bio & Medicine
Jan 22, 2012
0
0
